2-[3,5-bis(trifluoromethoxy)phenyl]-4-(3,3-difluoro-2-methoxypropyl)-5,6-dihydro-4H-1,3-oxazin-6-ol
C16H15F8NO5 — CID 177210080
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3,5-bis(trifluoromethoxy)phenyl]-4-(3,3-difluoro-2-methoxypropyl)-5,6-dihydro-4H-1,3-oxazin-6-ol
2-[3,5-bis(trifluoromethoxy)phenyl]-4-(3,3-difluoro-2-methoxypropyl)-5,6-dihydro-4H-1,3-oxazin-6-ol (PubChem CID 177210080) has the molecular formula C16H15F8NO5 and a molecular weight of 453.28 g/mol. Its IUPAC name is 2-[3,5-bis(trifluoromethoxy)phenyl]-4-(3,3-difluoro-2-methoxypropyl)-5,6-dihydro-4H-1,3-oxazin-6-ol.
Molecular Properties
| Compound Name | 2-[3,5-bis(trifluoromethoxy)phenyl]-4-(3,3-difluoro-2-methoxypropyl)-5,6-dihydro-4H-1,3-oxazin-6-ol |
|---|---|
| PubChem CID | 177210080 |
| Molecular Formula | C16H15F8NO5 |
| Molecular Weight | 453.28 g/mol |
| Exact Mass | 453.08 |
| IUPAC Name | 2-[3,5-bis(trifluoromethoxy)phenyl]-4-(3,3-difluoro-2-methoxypropyl)-5,6-dihydro-4H-1,3-oxazin-6-ol |
| SMILES | COC(CC1CC(O)OC(c2cc(OC(F)(F)F)cc(OC(F)(F)F)c2)=N1)C(F)F |
| InChI | InChI=1S/C16H15F8NO5/c1-27-11(13(17)18)4-8-5-12(26)28-14(25-8)7-2-9(29-15(19,20)21)6-10(3-7)30-16(22,23)24/h2-3,6,8,11-13,26H,4-5H2,1H3 |
| InChIKey | KXVRYFNOKNOVOR-UHFFFAOYSA-N |
| XLogP | 4.01 |
| TPSA | 69.51 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.28 |
| LogP ≤ 5 | 4.01 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177210080 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.